Total Payments
$87,460
2024 Payments
$28,269
Companies
13
Transactions
211
Medicare Patients
2,889
Medicare Billing
$255,751
Payment Breakdown by Category
Other$62,805 (71.8%)
Food & Beverage$8,848 (10.1%)
Consulting$7,750 (8.9%)
Travel$5,949 (6.8%)
Research$1,776 (2.0%)
Education$332.89 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60,305 | 16 | 69.0% |
| Food and Beverage | $8,848 | 141 | 10.1% |
| Consulting Fee | $7,750 | 6 | 8.9% |
| Travel and Lodging | $5,949 | 40 | 6.8% |
| Grant | $2,500 | 1 | 2.9% |
| Unspecified | $1,776 | 3 | 2.0% |
| Education | $332.89 | 4 | 0.4% |
Payments by Type
General
$85,685
208 transactions
Research
$1,776
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $70,848 | 64 | $0 (2024) |
| Abbott Laboratories | $5,788 | 93 | $0 (2024) |
| Medtronic, Inc. | $4,281 | 23 | $0 (2023) |
| Boston Scientific Corporation | $3,500 | 14 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $1,776 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $259.06 | 3 | $0 (2023) |
| ABIOMED | $246.05 | 2 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $245.53 | 2 | $0 (2018) |
| CVRx, Inc. | $153.36 | 1 | $0 (2023) |
| Novo Nordisk Inc | $134.07 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,269 | 51 | E.R. Squibb & Sons, L.L.C. ($23,911) |
| 2023 | $40,749 | 81 | E.R. Squibb & Sons, L.L.C. ($36,203) |
| 2022 | $12,343 | 28 | E.R. Squibb & Sons, L.L.C. ($10,733) |
| 2021 | $2,923 | 10 | Medtronic, Inc. ($2,584) |
| 2020 | $275.99 | 12 | Abbott Laboratories ($275.99) |
| 2019 | $1,777 | 18 | Abbott Laboratories ($1,537) |
| 2018 | $953.98 | 9 | Abbott Laboratories ($537.14) |
| 2017 | $169.86 | 2 | Philips Electronics North America Corporation ($85.32) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,375.00 | General |
| Category: Cardiovascular | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Travel and Lodging | Cash or cash equivalent | $144.72 | General |
| Category: Cardiovascular | ||||||
| 12/17/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $95.61 | General |
| Category: Heart Failure | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,916.00 | General |
| Category: Cardiovascular | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.44 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Travel and Lodging | Cash or cash equivalent | $189.81 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $90.91 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $5.30 | General |
| Category: Cardiovascular | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $74.22 | General |
| Category: Cardiovascular | ||||||
| 10/25/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: Heart Failure | ||||||
| 10/17/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $102.38 | General |
| Category: Heart Failure | ||||||
| 09/07/2024 | Lexicon Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $1,217.94 | Research |
| Study: SONATA-HCM | ||||||
| 09/07/2024 | Lexicon Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $347.59 | Research |
| Study: SONATA-HCM | ||||||
| 09/07/2024 | Lexicon Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $210.00 | Research |
| Study: SONATA-HCM | ||||||
| 09/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: Cardiovascular | ||||||
| 08/30/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Neuromodulation | ||||||
| 08/19/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Heart Failure | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $118.61 | General |
| Category: Cardiovascular | ||||||
| 08/09/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $840.50 | General |
| Category: General - Therapies_CRM | ||||||
| 08/08/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $230.28 | General |
| Category: General - Therapies_CRM | ||||||
| 08/08/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $226.03 | General |
| Category: General - Therapies_CRM | ||||||
| 08/08/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $219.32 | General |
| Category: General - Therapies_CRM | ||||||
| 08/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: Cardiovascular | ||||||
| 08/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $361.81 | General |
| Category: General - Therapies_CRM | ||||||
| 08/01/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: General - Therapies_CRM | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SONATA-HCM | Lexicon Pharmaceuticals, Inc. | $1,776 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,356 | 1,987 | $375,197 | $120,514 |
| 2022 | 20 | 1,225 | 1,720 | $339,760 | $103,994 |
| 2021 | 12 | 308 | 428 | $97,800 | $31,243 |
Total Patients
2,889
Total Services
4,135
Medicare Billing
$255,751
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 245 | $65,465 | $21,206 | 32.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 201 | $51,858 | $18,848 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 106 | 143 | $50,984 | $18,612 | 36.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 171 | $30,609 | $10,599 | 34.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 56 | $28,083 | $7,483 | 26.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $19,391 | $6,053 | 31.2% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 37 | 191 | $23,302 | $5,917 | 25.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 52 | 55 | $14,520 | $4,905 | 33.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 93 | 93 | $17,019 | $4,585 | 26.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 87 | 88 | $16,104 | $4,415 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 32 | 54 | $10,584 | $3,996 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $8,869 | $2,511 | 28.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 24 | $8,280 | $2,462 | 29.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 86 | 119 | $7,616 | $2,244 | 29.5% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 17 | 17 | $4,641 | $1,323 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 19 | $3,492 | $1,189 | 34.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 13 | 13 | $3,575 | $1,081 | 30.3% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 31 | 32 | $2,048 | $583.20 | 28.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 67 | 95 | $1,710 | $516.12 | 30.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 31 | 31 | $1,705 | $499.30 | 29.3% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 46 | 46 | $1,380 | $390.44 | 28.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 34 | $1,394 | $347.95 | 25.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 87 | 120 | $960.00 | $282.01 | 29.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 12 | 12 | $552.00 | $166.20 | 30.1% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 26 | 27 | $486.00 | $140.25 | 28.9% |
About Dr. Ankit Bhatia, M.D
Dr. Ankit Bhatia, M.D is a Internal Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1801200944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankit Bhatia, M.D has received a total of $87,460 in payments from pharmaceutical and medical device companies, with $28,269 received in 2024. These payments were reported across 211 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($60,305).
As a Medicare-enrolled provider, Bhatia has provided services to 2,889 Medicare beneficiaries, totaling 4,135 services with total Medicare billing of $255,751. Data is available for 3 years (2021–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Cincinnati, OH
- Active Since 06/17/2014
- Last Updated 04/06/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801200944
Products in Payments
- CAMZYOS (Drug) $69,826
- SYNCHROMED (Device) $2,500
- CARDIOMEMS (Device) $2,370
- CardioMEMS HF System (Device) $1,645
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $601.71
- INTELLIS ADAPTIVESTIM (Device) $328.36
- Ensite Cardiac Mapping System (Device) $312.31
- REVEAL LINQ (Device) $293.88
- Mitra Clip system (Device) $283.68
- Impella (Device) $246.05
- HeartMate 3 Left Ventricular Dev (Device) $224.41
- PROCLAIM (Device) $206.63
- VANTA ADAPTIVESTIM (Device) $197.22
- Barostim Neo System (Device) $153.36
- LifeVest (Device) $93.01
- Cardiovascular- Research only (Device) $92.54
- IGT_D Coronary (Device) $85.32
- GENERAL - THERAPIES (Device) $84.54
- RESTORE (Device) $84.15
- RESONATE (Device) $80.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cincinnati
Jonathan Bernstein, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Nelson Watts, M.d, M.D
Internal Medicine — Payments: $788,194
Internal Medicine $788,194
Robert Baughman, M.d, M.D
Internal Medicine — Payments: $766,919
Internal Medicine $766,919
Mark Andolina, Md, MD
Internal Medicine — Payments: $469,821
Internal Medicine $469,821
Amit Govil, M.d, M.D
Internal Medicine — Payments: $410,360
Internal Medicine $410,360
Vincent Martin, Md, MD
Internal Medicine — Payments: $332,673
Internal Medicine $332,673